CSP is the antigen in the most advanced malaria vaccine, RTS,S, which partially protects young children from disease [49, 50] and SSP2/TRAP has shown great promise in a number of human challenge studies [19, 48, 51, 52]. The gene discussed is SENP7; the disease is malaria.